Corvidia Therapeutics   Report issue

For profit Phase 2
Founded: Waltham MA United States (2014)
Status: Acquired by Novo Nordisk (2020)

Organization Overview

First Clinical Trial
2016
NCT02868229
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Corvidia Therapeutics